We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
-10.62%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
–
Cap. Flow
+$219M
Cap. Flow
% of AUM
174.4%
Top 10 Holdings %
Top 10 Hldgs %
48.75%
Holding
294
New
294
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$51.5M |
| 2 |
Blue Bird Corp
BLBD
|
+$7.99M |
| 3 |
Ovintiv
OVV
|
+$1.11M |
| 4 |
Canadian Natural Resources
CNQ
|
+$996K |
| 5 |
Ryder
R
|
+$818K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.89% |
| 2 | Consumer Discretionary | 7.76% |
| 3 | Technology | 6.03% |
| 4 | Financials | 5.46% |
| 5 | Consumer Staples | 4.78% |
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for TLP Group, which disclosed 294 positions worth $126M. Its ten largest holdings account for 49% of the portfolio.
Its largest position is Aimmune Therapeutics: 2,781,259 shares worth $51.3M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, followed by Consumer Discretionary and Technology.
- TLP Group's largest Q4 2015 buy was Aimmune Therapeutics: 2,781,259 shares worth $51.3M.
- TLP Group's ten largest holdings make up 49% of its $126M portfolio in Q4 2015.
- TLP Group disclosed 294 positions in Q4 2015, its first 13F filing on record.
Based on TLP Group's 13F filing for Q4 2015, filed 9 Feb 2016.